Haemokinesis’s board includes ASX-listed wealth platform Praemium’s former managing director Michael Ohanessian and Pacific Smiles Group founder Alex Abrahams.
ASX-listed Praemium has rejected a non-binding offer to merge with larger competitor Netwealth and form a wealth administration powerhouse with $94 billion under control.
The wealth platform pioneer failed to capitalise on its head start, but a new CEO believes the fintech can meet and even surpass its much-hyped rivals.